Use of Immune Profiling Panel to assess the immune response of septic patients for prediction of worsening as a composite endpoint.

导出 LinkOut

翻译打印收藏纠错

作者： Estelle,Peronnet ^[1] ; Gabriel,Terraz ^[2] ; Elisabeth,Cerrato ^[3] ; Katia,Imhoff ^[4] ; Sophie,Blein ^[3] ; Karen,Brengel-Pesce ^[5] ; Maxime,Bodinier ^[6] ; Aurore,Fleurie ^[6] ; Thomas,Rimmelé ^[3] ; Anne-Claire,Lukaszewicz ^[5] ; Guillaume,Monneret ^[3] ; Jean-François,Llitjos ^[5]

作者单位： Joint Research Unit HCL-bioMérieux, EA 7426 "Pathophysiology of Injury-Induced Immunosuppression" (Université Claude Bernard Lyon 1 - Hospices Civils de Lyon, bioMérieux), Lyon, France. estelle.peronnet@biomerieux.com. ^[1] Open Innovation and Partnerships (OI&P), bioMérieux S.A., Marcy-l'Etoile, France. estelle.peronnet@biomerieux.com. ^[2] Joint Research Unit HCL-bioMérieux, EA 7426 "Pathophysiology of Injury-Induced Immunosuppression" (Université Claude Bernard Lyon 1 - Hospices Civils de Lyon, bioMérieux), Lyon, France. ^[3] EFOR, Champagne-au-Mont-d'Or, France. ^[4] Open Innovation and Partnerships (OI&P), bioMérieux S.A., Marcy-l'Etoile, France. ^[5] Data Science, bioMérieux S.A., Marcy l'Etoile, France. ^[6] Anaesthesia and Critical Care Medicine Department, Hospices Civils de Lyon, Edouard Herriot Hospital, Lyon, France. ^[7] Immunology Laboratory, Edouard Herriot Hospital - Hospices Civils de Lyon, Lyon, France. ^[8]